The FDA approved the first-in-class targeted therapy based on a clinical trial evaluating overall survival among adults with previously treated metastatic pancreatic adenocarcinoma.
At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
Five-year survival after Hodgkin lymphoma does not eliminate excess mortality risk. What does the long-term pattern of deaths reveal about survivorship after the disease?
Five-year survival after Hodgkin lymphoma does not eliminate excess mortality risk. What does the long-term pattern of deaths reveal about survivorship after the disease?
Consultant360’s Photoclinic Challenge is an interactive quiz based on an image featured in a Photoclinic article. View the slideshow for a brief overview of the case, patient history, and a key hint.
SDM visits are a cornerstone of Medicare-covered lung cancer screening—but do you know how they influence whether patients return year after year? Take this brief quiz to test your knowledge!
Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
In this Consultant Case Report Insights, Nandini N. Patel, OMS III, provides an overview of her study, “Metastatic Malignant Melanoma from Unknown Origin to the Jejunum: A Case Report.” In the video...
Author-selected classifications for 2026 submissions highlight the breadth of practical, peer-reviewed, clinical education at Consultant, with dermatological disorders, pediatrics, primary care, cancer, and...
In the latest installment of the Myelofibrosis Caregiver Interview Series, Tim F. from Pittsburgh, PA, talks with Fadi Haddad, MD about the caregiver perspective, highlighting the substantial day-to-day...
Monitoring treatment response in myelofibrosis requires a balanced assessment of patient-reported symptoms, objective scoring tools, hematologic parameters, and spleen size. In part 1 of this Myelofibrosis...